These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 38499446)
21. Antifungal activity of phlorotannins against dermatophytes and yeasts: approaches to the mechanism of action and influence on Candida albicans virulence factor. Lopes G; Pinto E; Andrade PB; Valentão P PLoS One; 2013; 8(8):e72203. PubMed ID: 23951297 [TBL] [Abstract][Full Text] [Related]
22. Dermatophytes growth curve and in vitro susceptibility test: a broth micro-titration method. Alió AB; Mendoza M; Zambrano EA; Díaz E; Cavallera E Med Mycol; 2005 Jun; 43(4):319-25. PubMed ID: 16110777 [TBL] [Abstract][Full Text] [Related]
23. Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method. Bhatia VK; Sharma PC Indian J Med Microbiol; 2015; 33(4):533-7. PubMed ID: 26470960 [TBL] [Abstract][Full Text] [Related]
24. Antifungal drug susceptibility profile of clinically important dermatophytes and determination of point mutations in terbinafine-resistant isolates. Salehi Z; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1841-1846. PubMed ID: 29980898 [TBL] [Abstract][Full Text] [Related]
25. Flurbiprofen, a unique non-steroidal anti-inflammatory drug with antimicrobial activity against Trichophyton, Microsporum and Epidermophyton species. Chowdhury B; Adak M; Bose SK Lett Appl Microbiol; 2003; 37(2):158-61. PubMed ID: 12859660 [TBL] [Abstract][Full Text] [Related]
26. Antifungal activity of Ocimum gratissimum towards dermatophytes. Silva MR; Oliveira JG; Fernandes OF; Passos XS; Costa CR; Souza LK; Lemos JA; Paula JR Mycoses; 2005 May; 48(3):172-5. PubMed ID: 15842332 [TBL] [Abstract][Full Text] [Related]
27. Antifungal activity of a soil isolate of Pseudomonas chlororaphis against medically important dermatophytes and identification of a phenazine-like compound as its bioactive metabolite. Ranjbariyan A; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M J Mycol Med; 2014 Jun; 24(2):e57-64. PubMed ID: 24746720 [TBL] [Abstract][Full Text] [Related]
28. Antifungal Activity of Ellagic Acid In Vitro and In Vivo. Li ZJ; Guo X; Dawuti G; Aibai S Phytother Res; 2015 Jul; 29(7):1019-25. PubMed ID: 25919446 [TBL] [Abstract][Full Text] [Related]
29. Terbinafine resistance in Trichophyton mentagrophytes and Trichophyton rubrum in the Czech Republic: A prospective multicentric study. Kolarczyková D; Lysková P; Švarcová M; Kuklová I; Dobiáš R; Mallátová N; Kolařík M; Hubka V Mycoses; 2024 Feb; 67(2):e13708. PubMed ID: 38404204 [TBL] [Abstract][Full Text] [Related]
30. Comparison of disk diffusion method and broth microdilution method for antifungal susceptibility testing of dermatophytes. Esteban A; Abarca ML; Cabañes FJ Med Mycol; 2005 Feb; 43(1):61-6. PubMed ID: 15712608 [TBL] [Abstract][Full Text] [Related]
31. Antifungal activity of xanthones: evaluation of their effect on ergosterol biosynthesis by high-performance liquid chromatography. Pinto E; Afonso C; Duarte S; Vale-Silva L; Costa E; Sousa E; Pinto M Chem Biol Drug Des; 2011 Mar; 77(3):212-22. PubMed ID: 21244637 [TBL] [Abstract][Full Text] [Related]
32. In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species. Gupta AK; Kohli Y; Batra R Med Mycol; 2005 Mar; 43(2):179-85. PubMed ID: 15832561 [TBL] [Abstract][Full Text] [Related]
33. In vitro evaluation of griseofulvin against clinical isolates of dermatophytes from Isfahan. Chadeganipour M; Nilipour S; Havaei A Mycoses; 2004 Dec; 47(11-12):503-7. PubMed ID: 15601457 [TBL] [Abstract][Full Text] [Related]
34. In vitro activity of Citrus bergamia (bergamot) oil against clinical isolates of dermatophytes. Sanguinetti M; Posteraro B; Romano L; Battaglia F; Lopizzo T; De Carolis E; Fadda G J Antimicrob Chemother; 2007 Feb; 59(2):305-8. PubMed ID: 17118937 [TBL] [Abstract][Full Text] [Related]
35. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens. Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753 [TBL] [Abstract][Full Text] [Related]
36. Common dermatophytes and in vitro anti-fungal susceptibility testing in patients attending the Dermatological Clinic at the Hospital for Tropical Medicine, Bangkok. Muangkaew W; Wongsuk T; Luplertlop N New Microbiol; 2017 Jul; 40(3):175-179. PubMed ID: 28513812 [TBL] [Abstract][Full Text] [Related]
37. In vitro antifungal activity of micafungin and caspofungin against dermatophytes isolated from China. Bao YQ; Wan Z; Li RY Mycopathologia; 2013 Feb; 175(1-2):141-5. PubMed ID: 22983900 [TBL] [Abstract][Full Text] [Related]
38. Phylogeny, Antifungal Susceptibility, and Point Mutations of Pashootan N; Shams-Ghahfarokhi M; Chaichi Nusrati A; Salehi Z; Asmar M; Razzaghi-Abyaneh M Front Cell Infect Microbiol; 2022; 12():851769. PubMed ID: 35372131 [TBL] [Abstract][Full Text] [Related]
39. Susceptibility of clinically important dermatophytes against statins and different statin-antifungal combinations. Nyilasi I; Kocsubé S; Krizsán K; Galgóczy L; Papp T; Pesti M; Nagy K; Vágvölgyi C Med Mycol; 2014 Feb; 52(2):140-8. PubMed ID: 24004389 [TBL] [Abstract][Full Text] [Related]
40. Antioxidant and antifungal activities of marrubiin, extracts and essential oil from Marrubium vulgare L. against pathogenic dermatophyte strains. Rezgui M; Majdoub N; Mabrouk B; Baldisserotto A; Bino A; Ben Kaab LB; Manfredini S J Mycol Med; 2020 Apr; 30(1):100927. PubMed ID: 31983544 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]